Pinned: #PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EUÂ as we expand global access to obesity care. Read more here: https://www.novonordisk.com/
https://nitter.poast.org/novonordisk/status/2077427131135525277#m
Published: July 15, 2026 16:16
#PRESS Our GLP-1 pill for the treatment of obesity and injectable semaglutide 7.2 mg is approved in the EUÂ as we expand global access to obesity care. Read more here: novonordisk.com/
Pinned: #PRESS Novo Nordisk’s haemophilia A product demonstrated positive results in long-term safety and efficacy in the phase 3 FRONTIER extension study as presented at ISTH 2026. Read more here: https://www.novonordisk.com
https://nitter.poast.org/novonordisk/status/2075914123162919094#m
Published: July 11, 2026 12:04
#PRESS Novo Nordisk’s haemophilia A product demonstrated positive results in long-term safety and efficacy in the phase 3 FRONTIER extension study as presented at ISTH 2026. Read more here: novonordisk.com
#PRESS: We’re showcasing new data across our haemophilia portfolio at the ISTH Congress 2026.
Learn more in the press release here: https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=916574
https://nitter.poast.org/novonordisk/status/2070494404243059019#m
Published: June 26, 2026 13:08
#PRESS: We’re showcasing new data across our haemophilia portfolio at the ISTH Congress 2026.
Learn more in the press release here: novonordisk.com/news-and-med…